Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MPI | P34949 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.40 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.39 |
| ▸ | ACACA | Q13085 | 2/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29396258 | 1.00 | CYP11B1 (0.56) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL13049747 | 0.97 | CYP11B1 (0.53) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL13458897 | 0.97 | CYP11B1 (0.53) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL22101164 | 0.92 | CYP11B1 (0.51) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL1543078 | 0.90 | CYP11B1 (0.50) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL9976745 | 0.89 | CYP11B1 (0.51) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL13458690 | 0.88 | CYP11B1 (0.53) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL18101983 | 0.87 | HPRT1 (0.45) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL16696480 | 0.86 | CYP11B1 (0.47) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL14581511 | 0.84 | CYP11B1 (0.45) | CYP11B1ALDH1A1MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11362285-B2 | Semiconducting material and naphthofurane matrix compound for it | NOVALED GMBH (DE) | 2022-06-14 | — | — | US | disclosed |
| US-10862052-B2 | Electrically doped organic semiconducting material and organic light emitting device comprising it | NOVALED GMBH (DE) | 2020-12-08 | — | — | US | disclosed |
| US-10811608-B2 | N-doped semiconducting material comprising two metal dopants | NOVALED GMBH (DE) | 2020-10-20 | — | — | US | disclosed |
| US-RE48156-E1 | Electronic device comprising an organic semiconducting material | NOVALED GMBH (DE) | 2020-08-11 | — | — | US | disclosed |
| US-10396293-B2 | Electronic or optoelectronic device comprising an anchored thin molecular layer, process for its preparation and compound used therein | NOVALED GMBH (DE) | 2019-08-27 | — | — | US | disclosed |
| EP-2786435-B1 | Compounds | NOVALED GMBH (DE) | 2019-07-17 | — | — | EP | disclosed |
| EP-2860782-B1 | Semiconducting material comprising a phosphine oxide matrix and metal salt | NOVALED GMBH (DE) | 2019-04-17 | — | — | EP | disclosed |
| US-20180351100-A1 | N-Doped Semiconducting Material Comprising Two Metal Dopants | NOVALED GMBH (DE) | 2018-12-06 | — | — | US | disclosed |
| US-10069078-B2 | Semiconducting material comprising aza-substituted phosphine oxide matrix and metal salt | NOVALED GMBH (DE) | 2018-09-04 | — | — | US | disclosed |
| US-20180182960-A1 | Organic Light Emitting Device Comprising Polar Matrix and Metal Dopant | NOVALED GMBH (DE) | 2018-06-28 | — | — | US | disclosed |
| US-8637858-B2 | Tandem white OLED | NOVALED AG (DE) | 2014-01-28 | — | — | US | disclosed |
| US-20130200341-A1 | Electronic Device Comprising an Organic Semiconducting Material | NOVALED AG (DE) | 2013-08-08 | — | — | US | disclosed |
| US-20120283437-A1 | Organic Electronic Device Comprising an Organic Semiconducting Material | NOVALED AG (DE) | 2012-11-08 | — | — | US | disclosed |
| US-20120235122-A1 | Organic Memory Element | TECHNISCHE UNIVERSITAET DRESDEN (DE) | 2012-09-20 | — | — | US | disclosed |
| US-20120119191-A1 | Chemical Compound for Organic Electronic Device and Organic Electronic Device | NOVALED AG (DE) | 2012-05-17 | — | — | US | disclosed |
| US-20120074392-A1 | Tandem White OLED | NOVALED AG (DE) | 2012-03-29 | — | — | US | disclosed |
| US-20120012794-A1 | Bridged Pyridoquinazoline or Phenanthroline Compounds and Organic Semiconducting Material Comprising That Compound | NOVALED AG (DE) | 2012-01-19 | — | — | US | disclosed |
| US-20110220200-A1 | Organic Photoactive Device | NOVALED AG (DE) | 2011-09-15 | — | — | US | disclosed |
| US-20080246395-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2008-10-09 | — | — | US | disclosed |
| US-20080246395-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11362285-B2 | Semiconducting material and naphthofurane matrix compound for it | NES, NQO1, VIM | CYP11B1 1435/4885ALDH1A1 1096/4885MEN1 1255/4885 |
| US-20120119191-A1 | Chemical Compound for Organic Electronic Device and Organic Electronic Device | SLCO4C1, OR10J3, EPCAM | CYP11B1 100/4885ALDH1A1 409/4885MEN1 2165/4885 |
| US-20120283437-A1 | Organic Electronic Device Comprising an Organic Semiconducting Material | OR10J3, OR51E2, ICMT | CYP11B1 1746/4885ALDH1A1 264/4885MEN1 1309/4885 |
| US-10069078-B2 | Semiconducting material comprising aza-substituted phosphine oxide matrix and metal salt | AZI2, ITPA, TET3 | CYP11B1 4207/4885ALDH1A1 3761/4885MEN1 282/4885 |
| US-20120012794-A1 | Bridged Pyridoquinazoline or Phenanthroline Compounds and Organic Semiconducting Material Comprising That Compound | PNPO, SDHB, PAH | CYP11B1 1440/4885ALDH1A1 1384/4885MEN1 243/4885 |
| US-10396293-B2 | Electronic or optoelectronic device comprising an anchored thin molecular layer, process for its preparation and compound used therein | EPCAM, OR10J3, OR51E2 | CYP11B1 1289/4885ALDH1A1 1046/4885MEN1 2507/4885 |
| US-10862052-B2 | Electrically doped organic semiconducting material and organic light emitting device comprising it | C1S, C5, HCN2 | CYP11B1 2279/4885ALDH1A1 919/4885MEN1 855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.